What is Zoetis's cumulative gross losses and impairments?

Zoetis (ZTS) reported cumulative gross losses and impairments of $536.00M in Q1 2026.

How has Zoetis's cumulative gross losses and impairments changed year-over-year?

Zoetis's cumulative gross losses and impairments decreased by 0.0% year-over-year, from $536.00M to $536.00M.

What is the long-term trend for Zoetis's cumulative gross losses and impairments?

Over 5 years (2020 to 2025), Zoetis's cumulative gross losses and impairments has grown at a 0.0% compound annual growth rate (CAGR), from $536.00M to $536.00M.

What does cumulative gross losses and impairments mean?

The total amount of value lost on investments that hasn't been officially recorded as a loss on the income statement yet.

Discontinued — last reported Q3 '23

Equity

Cumulative Gross Losses and Impairments

Zoetis Cumulative Gross Losses and Impairments remained flat by 0.0% to $536.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $536.00M to $536.00M. Over 5 years (FY 2020 to FY 2025), Cumulative Gross Losses and Impairments shows relatively stable performance with a 0.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionEquity

CategoryRisk

SignalLower is better

VolatilityModerate

First reportedQ4 2019

Last reportedQ3 2023

How to read this metric

A rising trend indicates persistent underperformance or market-wide stress affecting the firm's long-term holdings.

Detailed definition

This metric aggregates all unrealized losses and impairment charges on investments that have not yet been recognized in...

Peer comparison

Reported in equity or comprehensive income disclosures for firms with significant investment portfolios.

Metric ID: cumulative_gross_losses_and_impairments

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M	$536.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
YoY Change	—	—	—	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%

Range$536.00M – $536.00M

CAGR+0.0%

Avg YoY Growth+0.0%

Median YoY Growth+0.0%

Current Streak19+ quarters growth

Cumulative Gross Losses and Impairments at Other Companies

Merck & Co.MRK View metric

Frequently Asked Questions

What is Zoetis's cumulative gross losses and impairments?: Zoetis (ZTS) reported cumulative gross losses and impairments of $536.00M in Q1 2026.
How has Zoetis's cumulative gross losses and impairments changed year-over-year?: Zoetis's cumulative gross losses and impairments decreased by 0.0% year-over-year, from $536.00M to $536.00M.
What is the long-term trend for Zoetis's cumulative gross losses and impairments?: Over 5 years (2020 to 2025), Zoetis's cumulative gross losses and impairments has grown at a 0.0% compound annual growth rate (CAGR), from $536.00M to $536.00M.
What does cumulative gross losses and impairments mean?: The total amount of value lost on investments that hasn't been officially recorded as a loss on the income statement yet.